VOYAGER THERAPEUTICS INC. - COMMON STOCK

6.0400

03-January-25 15:45:00

15 minutes delayed

Stocks

+0.0700

+1.17%

Today's range

5.9800 - 6.1800

ISIN

N/A

Source

NASDAQ

Voyager Therapeutics Receives FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease

26 Apr 2021 07:00:01 By Nasdaq GlobeNewswire
Voyager Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates

25 Feb 2021 15:01:01 By Nasdaq GlobeNewswire
Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference

18 Feb 2021 15:01:00 By Nasdaq GlobeNewswire
Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program

02 Feb 2021 15:01:00 By Nasdaq GlobeNewswire
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 Jan 2021 15:03:16 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.